Skip to main content
. 2007 Jun 19;97(1):92–97. doi: 10.1038/sj.bjc.6603847

Table 2. Global results for EGFR, Akt and MAPK expression.

  Primary tumour (%) Liver metastases (%) Lung metastases (%) Brain metastases (%) Bone metastasis (%)
EGFR
Positive 51 (52) 39 (48) 5 (42) 1 (25) 0 (0)
Negative 47 (48) 45 (52) 7 (58) 3 (75) 1 (100)
           
Akt
Positive 73 (74) 61 (73) 5 (42) 4 (100) 1 (100)
Negative 25 (26) 23 (27) 7 (58) 0 (0) 0 (0)
           
MAPK
Positive 71 (70) 62 (74) 8 (67) 0 (0) 1 (100)
Negative 27 (30) 22 (26) 4 (33) 4 (100) 0 (0)